These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9034862)

  • 1. The role of polymorphic donor peptides in allograft recognition and rejection.
    Fabre JW
    Immunol Rev; 1996 Dec; 154():21-43. PubMed ID: 9034862
    [No Abstract]   [Full Text] [Related]  

  • 2. Modulation of the immune response with major histocompatability class II peptides via the indirect pathway of allorecognition after kidney and small bowel transplantation.
    Gasser M; Lenhard SM; Otto C; Kist-van Holthe JE; Navarro E; Timmermann W; Ulrichs K; Thiede A; Waaga AM
    Transplant Proc; 2002 Sep; 34(6):2244-5. PubMed ID: 12270384
    [No Abstract]   [Full Text] [Related]  

  • 3. The contribution of peptides to T cell allorecognition and allograft rejection.
    Benichou G; Fedoseyeva EV
    Int Rev Immunol; 1996; 13(3):231-43. PubMed ID: 8782744
    [No Abstract]   [Full Text] [Related]  

  • 4. Indirect T cell recognition in allograft rejection.
    Bradley JA
    Int Rev Immunol; 1996; 13(3):245-55. PubMed ID: 8782745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rejection of skin allografts by indirect allorecognition of donor class I major histocompatibility complex peptides.
    Fangmann J; Dalchau R; Fabre JW
    Transplant Proc; 1993 Feb; 25(1 Pt 1):183-4. PubMed ID: 8438266
    [No Abstract]   [Full Text] [Related]  

  • 6. Elucidation of key peptide determinants involved in an indirect T-cell allorecognition pathway of rat kidney allograft rejection.
    Benham AM; Fabre JW
    Transplant Proc; 1995 Feb; 27(1):547-8. PubMed ID: 7879093
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of interferon alpha in allograft rejection.
    Benizri EJ; Gugenheim J; Bernard G; Tovey MG
    Transplant Proc; 1995 Feb; 27(1):413. PubMed ID: 7879043
    [No Abstract]   [Full Text] [Related]  

  • 8. T-cell recognition of donor class I major histocompatibility complex peptides during allograft rejection.
    Fangmann J; Dalchau R; Sawyer GJ; Priestley CA; Fabre JW
    Transplant Proc; 1993 Feb; 25(1 Pt 1):187-8. PubMed ID: 8438268
    [No Abstract]   [Full Text] [Related]  

  • 9. Identification of immunodominant donor MHC peptides following rejection and donor strain transfusion-induced tolerance of heart allografts in adult rats.
    van Denderen B; Pêche H; Gagne K; Usal C; Cuturi MC; Soulillou JP
    Eur J Immunol; 2001 May; 31(5):1333-9. PubMed ID: 11465090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptides derived from alpha-helices of allogeneic class I major histocompatibility complex antigens are potent inducers of CD4+ and CD8+ T cell and B cell responses after cardiac allograft rejection.
    Shirwan H; Leamer M; Wang HK; Makowka L; Cramer DV
    Transplantation; 1995 Feb; 59(3):401-10. PubMed ID: 7871571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgM and IgG alloantibody responses to MHC class I and II following rat renal allograft rejection. Effects of transplantectomy and posttransplantation blood transfusion.
    Wray DW; Baldwin WM; Sanfilippo F
    Transplantation; 1992 Jan; 53(1):167-74. PubMed ID: 1370736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The immune response to kidney allograft. Part I: the role of MHC antigens, antigen-presenting cells, and lymphocytes in alloantigen recognition; two-signal activation of T cells].
    Kusztal M; Jezior D; Weyde W; Krajewska M; Klinger M
    Postepy Hig Med Dosw (Online); 2007; 61():13-20. PubMed ID: 17245313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of CD8+ and CD4+ T cells in the rejection of murine intestinal allografts.
    He G; Hart J; Thistlethwaite JR; Newell KA
    Transplant Proc; 1998 Sep; 30(6):2592-3. PubMed ID: 9745505
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunologic mechanisms of hepatic allograft rejection.
    Vierling JM
    Semin Liver Dis; 1992 Feb; 12(1):16-27. PubMed ID: 1570548
    [No Abstract]   [Full Text] [Related]  

  • 15. Inducing unresponsiveness in allopeptide specific T cells: are altered peptide ligands the answer?
    Jones ND
    Transplantation; 2000 Aug; 70(4):566-7. PubMed ID: 10972208
    [No Abstract]   [Full Text] [Related]  

  • 16. Induction of T-cell response to cryptic MHC determinants during allograft rejection.
    Boisgérault F; Anosova NG; Tam RC; Illigens BM; Fedoseyeva EV; Benichou G
    Hum Immunol; 2000 Dec; 61(12):1352-62. PubMed ID: 11163093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alloantigen processing and presentation.
    Tambur AR; Gebel HM
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1031-7. PubMed ID: 8719446
    [No Abstract]   [Full Text] [Related]  

  • 18. Direct and indirect antigen recognition: the pathways to allograft immune rejection.
    Benichou G
    Front Biosci; 1999 May; 4():D476-80. PubMed ID: 10331992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of humoral immunity in pancreatic islet allo- and xenograft rejection.
    Ahn M; Sohn C; Chang E; Chu G; DeMatteo RP; Barker CF; Markmann JF
    Transplant Proc; 1996 Apr; 28(2):840-1. PubMed ID: 8623428
    [No Abstract]   [Full Text] [Related]  

  • 20. Intrathymic immunomodulation of sensitized rat recipients of cardiac allografts: requirements for allorecognition pathways.
    Stadlbauer TH; Onodera K; Schaub M; Korom S; Binder J; Sayegh MH; Kupiec-Weglinski JW
    Transplant Proc; 1997; 29(1-2):1016. PubMed ID: 9123176
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.